Major deal for EBOS with Chemist Warehouse

Company News

by Rachael Jones

Pharmaceutical company EBOS Group (ASX:EBO) has won the tender to act as the exclusive third party distributor of pharmaceutical products to more than 400 Chemist Warehouse and My Chemist stores in Australia.

The deal could bring approximately $1 billion in revenue in the first year of the agreement.

Having acquired Symbion in 2013, EBOS has grown to become a leading marketer and distributor of pharmaceutical products, with annual sales revenue of approximately NZ$7.5 billion and a market capitalisation of NZ$2.7 billion.

Shares in Ebos group (ASX:EBO) closed flat on Friday at $16.86.

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.